NIFTY 50▼23,995.35
-309.00 (-1.27%)
SENSEX▼78,782.24
-941.88 (-1.18%)
NIFTY BANK▼51,215.25
-458.65 (-0.89%)
TATA MOTORS▼824.10
-19.35 (-2.29%)
SUZLON ENERGY▼66.32
-1.82 (-2.67%)
TATA STEEL▼146.95
-2.80 (-1.87%)
INDIAN RAILWAY FINANCE CORP▼153.24
-4.87 (-3.08%)
TATA POWER▼429.05
-16.40 (-3.68%)
RAIL VIKAS NIGAM▼446.20
-24.75 (-5.26%)
RELIANCE INDUSTRIES▼1,302.15
-36.50 (-2.73%)
VODAFONE IDEA▼7.88
-0.57 (-6.75%)
ZOMATO▼245.08
-3.91 (-1.57%)
RELIANCE POWER▼42.03
-1.00 (-2.32%)
INDIAN RENEWABLE ENERGY▼205.38
-6.60 (-3.11%)
ADANI POWER▼585.00
-12.35 (-2.07%)
YES BANK▼20.33
-0.38 (-1.83%)
STATE BANK OF INDIA▲829.85
8.65 (1.05%)
NHPC▼83.30
-0.83 (-0.99%)
HDFC BANK▼1,714.10
-23.20 (-1.34%)
OLA ELECTRIC MOBILITY LTD▼80.84
-2.00 (-2.41%)
JIO FIN SERVICES LTD▼319.85
-6.35 (-1.95%)
INDIAN OIL CORP▼138.93
-6.06 (-4.18%)
BHARAT ELECTRONICS▼284.15
-4.50 (-1.56%)
MRF▼1,20,876.75
-2453.55 (-1.99%)
GTL INFRA▼2.11
-0.07 (-3.21%)
ADANI PORT & SEZ▼1,349.25
-45.15 (-3.24%)
JAIPRAKASH POWER VENTURES▼17.88
-0.59 (-3.19%)
ITC▼484.60
-5.70 (-1.16%)
- Nectar Lifesciences
Nectar Lifesciences Share Price
NECLIFE
₹39.69+₹0.71 (1.82%) TodayLast updated on 04 Nov, 2024 | 15:43 IST
Nectar Lifesciences Share Price Chart
Please wait...
About Nectar Lifesciences
Nectar Lifesciences Financials
Market cap  ₹845 Crs | Open ₹39.70 | Close ₹38.98 |
Circuit range ₹40.92 - ₹37.03 | Day range ₹37.50 - ₹40.00 | Year range ₹22.80 - ₹56.50 |
Volume 4,78,170 | Avg. traded ₹39.27 | Revenue (12m) ₹1,649 Crs |
Nectar LifesciencesNectar Lifesciences Limited is an India-based pharmaceutical company. The Company's business areas include active pharmaceutical ingredients (APIs) and intermediates, formulations/finished dosage formulations (FDF), menthol and mint derivatives, and empty hard gelatin capsules. The Company is engaged in the manufacturing of oral and sterile cephalosporin products. Its oral cephalosporins include cefixime, cefurozime axetil crystalline, cefuroxime axetil amorphous, cedpodoxime proxetil, cefprozil and cefdinir. Its sterile cephalosporins include cefotaxime sodium, ceftriaxone sodium, cefuroxime sodium, cefazolin sodium, ceftazidime pentahydrate and cefepime arginine. Its capacities include cefixime, cefuroxime axetil amorphous, cefuroxime axetil crystalline, cefotaxime sodium and ceftriaxone sodium. The Company offers contract manufacturing capabilities for solid dosage forms, such as tablets, capsules, dry powder oral suspension and granules and injectable for cephalosporins.
Nectar Lifesciences Key indicators
52 week high ₹56.50 | 52 week low ₹22.80 | P/E ratio 137.08 |
P/B ratio 0.72 | ROE 0.47% | ROCE 6.54% |
Dividend yield -- | Debt/Equity ratio 0.59 | EPS 0.22 |
Learn more
Featured in
Investment checklist: (2/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Nectar Lifesciences Fundamentals
Nectar Lifesciences Financial Ratios
Operating profit margin9.13% | Net profit margin0.26% |
ROE0.47% | ROA0.23% |
ROCE6.54% |
Learn more
Nectar Lifesciences Shareholder returns
1 day | 1 week | 1 month -6.81% |
3 months | 1 year | 3 years |
5 years |
Nectar Lifesciences Share Price history
| Day | Open | Close | Change % |
|---|---|---|---|
Fri, Nov 1 2024 | ₹38.00 | ₹38.98 | |
Thu, Oct 31 2024 | ₹37.10 | ₹37.70 | |
Wed, Oct 30 2024 | ₹34.80 | ₹35.93 | |
Tue, Oct 29 2024 | ₹33.35 | ₹34.22 | |
Mon, Oct 28 2024 | ₹32.25 | ₹33.27 | |
Fri, Oct 25 2024 | ₹35.00 | ₹33.27 | -4.59% |
Thu, Oct 24 2024 | ₹34.98 | ₹34.87 | |
Wed, Oct 23 2024 | ₹34.20 | ₹34.18 | -1.67% |
Nectar Lifesciences Shareholding Pattern
Promoters (55.8%) | Mutual Funds (0%) | Retail and other (40.94%) |
Foreign institutions-FII (3.24%) | Other domestic institutions (0.02%) |
Promoters
Learn more
More
Stocks Similar to Nectar Lifesciences
People also bought
Nectar Lifesciences News
